Parmar, M. T. (2026). Low Beta Is Not Low Risk: Evidence and Investor Implications from Five Indian Pharmaceutical Stocks, 2021–2025. International Journal of Engineering and Management Research, 16(3), 113–125. https://doi.org/10.31033/IJEMR/16.3.2026.1941